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Abstract
We studied the involvement of phosphatidylinositol 3-kinase (PI3-kinase) in the antigen-induced IL-4 production in a rat
mast cell line, RBL-2H3. The stimulation of IgE-sensitized RBL-2H3 cells by the antigen resulted in increased IL-4 mRNA
levels followed by increased IL-4 production. Wortmannin and LY294002, PI3-kinase inhibitors, partially reduced both the
antigen-induced increases in the IL-4 mRNA levels and IL-4 production in a concentration-dependent manner. Extracellular
signal-regulated kinase, p38 mitogen-activated protein kinase (p38 MAPK) and c-Jun N-terminal kinase (JNK), which
belong to the MAPK family, were activated by the antigen stimulation, and the activation of p38 MAPK in addition to JNK
was suppressed markedly by wortmannin. The phosphorylation of endogenous activating transcription factor-2, a substrate
of p38 MAPK, was also inhibited by wortmannin. The specific p38 MAPK inhibitor SB203580 partially inhibited the
antigen-induced IL-4 production at mRNA levels, but the MEK-1 inhibitor PD98059 enhanced it. These findings suggest
that the activation of PI3-kinase and p38 MAPK is partially responsible for the antigen-induced IL-4 production in RBL-
2H3 cells. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The antigen-induced aggregation of IgE binding to
high-a⁄nity IgE receptors (FcORI) on mast cells in-
duces degranulation, arachidonic acid release and
production of a variety of cytokines including IL-4
[1]. IL-4 plays central roles in Th2-type immune re-
sponses, such as IgE production and immediate al-
lergic in£ammation [2,3] and might be involved in
the exacerbation of allergic diseases.
Transcription of IL-4 gene has been studied in
T-cells and mast cells. Stimulation of T-cell receptors
induces the activation of two transcription factors;
nuclear factor of activated T-cell (NF-AT) and acti-
vator protein-1 (AP-1). NF-AT and AP-1 bind coop-
eratively to their cognate binding sites in IL-4 pro-
moter, and the binding of both NF-AT and AP-1 is
necessary for maximum transcription in T-cells [4].
In addition, the involvement of several other tran-
scription factors in IL-4 production by T-cells has
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also been suggested [5^7]. NF-AT is activated by the
antigen stimulation in mast cells [8], but the regula-
tion mechanism of IL-4 production in mast cells and
T-cells di¡ers from each other [9].
The aggregation of IgE/FcORI with the antigen
activates the tyrosine kinases, Lyn and Syk, followed
by the phosphorylation of phospholipase CQ and Vav
[10,11]. The activated phospholipase CQ generates
inositol polyphosphate and diacylglycerol, which in-
creases intracellular Ca2 level and activates protein
kinase C (PKC), respectively. The tyrosine phosphor-
ylation of Vav results in the activation of small
G-proteins, such as Ras and Rac [12,13]. The activa-
tion of these small G-proteins leads to the activation
of MAPK superfamily; extracellular signal-regulated
kinase (ERK), p38 MAPK and c-Jun N-terminal
kinase (JNK) [14,15]. The antigen stimulation of
mast cells induces the activation of these MAPKs
[16^18]. The antigen-induced degranulation of mast
cells is highly dependent on both the activation of
PKC and the increase in cytosolic Ca2 concentra-
tion [19]. In contrast, the arachidonic acid release
induced within a few minutes after the antigen stim-
ulation is dependent on both the phosphorylation of
cytosolic phospholipase A2 by ERK and the increase
in cytosolic Ca2 concentration [16]. In addition,
JNK is demonstrated to play crucial roles in the
production of IL-2 [20] and TNF-K [21] by mast
cells.
Phosphatidylinositol 3-kinase (PI3-kinase) is also
activated by the antigen-stimulation in mast cells
[22,23] and is implicated in various cellular re-
sponses, such as degranulation [22^24] and mem-
brane ru¥ing [23,25]. The roles of PI3-kinase have
been clari¢ed by using the selective inhibitors of PI3-
kinase, wortmannin [22] and LY294002 [26]. The
TNF-K production by the mouse mast cell line
MC/9 is inhibited by wortmannin [21]. PI3-kinase,
which converts phosphatidylinositol 4,5-bisphos-
phate to phosphatidylinositol 3,4,5-triphosphate, reg-
ulates the activation of the small G-protein Rac [27],
PKCh [28], the serine/threonine kinase Akt [29], and
MAPK family [18,21,30,31]. However, although sig-
ni¢cant roles of PI3-kinase in these signaling path-
ways have been described, the involvement of these
pathways activated by PI3-kinase in the antigen-in-
duced IL-4 production has not been elucidated. In
this study, we examined the involvement of PI3-ki-
nase and MAP kinases in the antigen-stimulated IL-4
production in rat mast cells.
2. Materials and methods
2.1. Cell treatment and measurement of IL-4
The rat mast cell line RBL-2H3 was kindly sup-
plied by Dr. Michael A. Beaven (National Institutes
of Health, Bethesda, MD, USA). RBL-2H3 cells
(2U105 cells) were incubated overnight in 0.4 ml of
Eagle’s minimum essential medium (EMEM) con-
taining 10% (v/v) fetal bovine serum (FBS, Flow
Laboratories, North Ridge, NSW, Australia) and
0.1% (v/v) conditioned medium of the DNP-speci¢c
IgE-producing hybridoma (kindly supplied by Dr.
Kazutaka Maeyama, Ehime University, Ehime, Ja-
pan) in each well of a 24-well cluster dish (Coster,
Cambridge, MA, USA). After three washes with
EMEM, the cells were incubated in 0.2 ml of
EMEM containing 5% FBS in the presence or ab-
sence of wortmannin (Biomol, Plymouth Meeting,
PA, USA), LY294002 (Biomol) SB203580 (Calbio-
chem-Novabiochem, San Diego, CA, USA), or
PD98059 (New England Biolabs, Beverly, MA,
USA) for 10 min. The cells were then stimulated
for the periods indicated by the antigen DNP-HSA
(50 ng/ml) (Sigma, St. Louis, MO, USA). The con-
ditioned medium was collected, centrifuged at 220Ug
and 4‡C for 5 min. The IL-4 levels in the supernatant
fraction were determined using a rat IL-4 ELISA kit
(BioSource, Camarillo, CA, USA). In some cases,
after the antigen stimulation, the cells were washed
with ice-cold EMEM, and then sonicated in 0.2 ml of
EMEM, and the IL-4 levels in the cell lysates were
determined as described above.
2.2. Semiquantitation of IL-4 mRNA by reverse
transcription-polymerase chain reaction
(RT-PCR)
RBL-2H3 cells (1U106 cells/well) in a 6-well clus-
ter dish (Coster) were incubated for various periods
in EMEM containing 5% FBS. After the antigen
stimulation as described above, total RNA was pre-
pared from each sample by acid guanidinium-phenol-
chloroform extraction, and the yield of RNA ex-
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tracted was determined by spectrophotometry. One
microgram of RNA from each sample was reverse
transcribed in 20 Wl of the bu¡er (50 mM Tris-HCl,
pH 8.3, 75 mM KCl and 3 mM MgCl2) containing
5 WM of random hexamer oligonucleotides (Gibco-
BRL, Gaithersberg, MD, USA), 200 U of the reverse
transcriptase from moloney murine leukemia virus
(Gibco-BRL), 0.5 mM deoxyribonucleoside triphos-
phates (dNTP, Pharmacia Biotech, Uppsala, Swe-
den) and 10 mM dithiothreitol. The PCR primers
for rat IL-4 were: (former) 5P-ACCTTGCTGTC-
ACCCTGTTCTTGC-3P and (reverse) 5P-GTTGTG-
AGCGTGGACTCATTC-3P, which amplify a 352-
base pair (bp) IL-4 DNA fragment. PCR was per-
formed for 25 cycles; 1 min denaturation at 94‡C,
1 min annealing at 58‡C, and 2 min extension at
72‡C, using a thermal cycler (GeneAmp PCR System
2400, Perkin Elmer Cetus, Norwalk, CT, USA). The
rat glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene (a housekeeping gene) was used as
an internal control as described before [32]. In such
conditions for RT-PCR, levels of each mRNA could
be determined semiquantitatively. The levels of
mRNA for IL-4 and GAPDH were quanti¢ed by
scanning densitometry, and the ratio of the IL-4
mRNA density to the GAPDH mRNA density in
each point was calculated.
2.3. In vitro assay for p38 MAPK
RBL-2H3 cells (1.0U106 cells/well) in a 6-well
cluster dish were washed with PIPES-bu¡er (25
mM PIPES, pH 7.2, 119 mM NaCl, 5 mM KCl,
5.6 mM glucose, 0.4 mM MgCl2 and 1 mM CaCl2),
and stimulated by the antigen DNP-HSA (50 ng/ml)
in 1.0 ml of PIPES bu¡er. After stimulation of the
cells for the periods indicated, the cells were lysed in
0.5 ml of lysis bu¡er (20 mM HEPES, pH 7.3, 1%
Triton X-100, 10% glycerol, 50 mM NaF, 2.5 mM
p-nitrophenylphosphate, 10 Wg/ml PMSF, 1 mM
Na3VO4, 5 Wg/ml leupeptin and 1 mM dithiothrei-
tol). The cell lysate was centrifuged at 18 600Ug and
4‡C for 20 min. To the supernatant fraction, 3 Wg
anti-p38 MAPK (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) and 20 Wl protein A-Sepharose
slurry (Pharmacia Biotech) were added and incu-
bated for 3 h at 4‡C. The immunoprecipitate of
p38 MAPK was washed with washing bu¡er (10
mM Tris-HCl, pH 7.4, 0.5% Triton X-100, 150
mM NaCl) and then washed with kinase assay bu¡er
(50 mM Tris-HCl, pH 7.5, 10 mM MgCl2) three
times each. The kinase reaction was initiated by add-
ing 20 Wl kinase bu¡er containing 500 ng ATF-2
(amino acids 1^505) (Santa Cruz Biotechnology),
10 WM ATP and 74 kBq [Q-32P]ATP (111 TBq/
mmol, DuPont/NEN, Boston, MA, USA). After in-
cubation for 30 min at 30‡C, the reactions were cen-
trifuged at 18 600Ug and 4‡C for 5 min, and ATF-2
in the supernatant fraction was separated on a 10%
SDS-PAGE gel. Phosphorylated ATF-2 was visual-
ized by Bioimage analyzer (GS-250, Bio-Rad, Mel-
ville, NY, USA) and by autoradiography.
2.4. Immunoblotting of p38 MAPK, phospho-p38
MAPK, phospho-JNK, JNK and ERK
After the antigen stimulation, the cells (5U105
cells/well) in a 12-well cluster dish (Coster) were lysed
in 0.075 ml of lysis bu¡er. Proteins in the cell lysate
were separated by SDS-PAGE and transferred onto
a nitrocellulose membrane (Schleicher and Schuell,
Dassel, Germany). p38 MAPK, phospho-p38
MAPK, phospho-JNK, JNK and ERK were immno-
blotted using polyclonal antibodies against the epi-
tope corresponding to amino acids 341^360 mapping
at the carboxy terminus of p38 MAPK (Santa Cruz
Biotechnology), p38 MAPK phosphorylated at Thr-
180 and Tyr-182 (New England Biolabs), JNK phos-
phorylated at Thr-183 and Tyr-185 (Promega, Mad-
ison, WI, USA), p54 JNK-2 (Santa Cruz Biotechnol-
ogy), and the epitope corresponding to amino acids
333^367 mapping at the carboxy terminus of p43
ERK (Upstate Biotechnology, Lake Placid, NY,
USA), respectively.
2.5. Immunoblotting of phospho-ATF-2 in nuclei
RBL-2H3 cells (1.0U106 cells/well) in a 6-well
cluster dish were stimulated by the antigen DNP-
HSA as described above. After incubation for the
periods indicated, the cells were harvested in ice-
cold phosphate-bu¡ered saline (pH 7.4). The cells
were incubated in 0.1 ml of Bu¡er A (10 mM
HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA,
1 mM DTT, and 1 mM PMSF) for 15 min on ice.
Nonidet P-40 (Sigma) was then added to make a
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¢nal concentration at 0.25%. The mixture was vor-
texed vigorously for 10 s and left on ice for 1 min.
Nuclei were pelleted by centrifugation at 3000Ug
and 4‡C for 5 min, and proteins in the pelleted nuclei
were extracted with 0.1 ml of Bu¡er B (20 mM
HEPES, pH 7.9, 400 mM KCl, 0.1 mM EDTA
1 mM DTT, and 1 mM PMSF) on ice for 30 min.
After centrifugation at 18 600Ug and 4‡C for 15 min,
the supernatant fractions were used as nuclear ex-
tracts. ATF-2 and phosphorylated ATF-2 in nuclear
extracts were immunoblotted using polyclonal anti-
bodies against the epitope corresponding to amino
acids 1^96 mapping at the amino terminus of human
ATF-2 (Santa Cruz, Biotechnology) and against
ATF-2 phosphorylated at Thr-71 (New England Bio-
labs), respectively.
2.6. Statistical analysis
Results are expressed as means þ S.E.M. of four
culture dishes in one representative experiment of
at least three independent experiments. Comparisons
of results were made by Student’s unpaired t-test.
Fig. 2. E¡ects of wortmannin on the antigen-induced IL-4 production. IgE-sensitized RBL-2H3 cells (2U105 cells (A,B) or 1U106
cells (C)) were treated for 10 min in the presence of the indicated concentrations of wortmannin, then stimulated with DNP-HSA
(50 ng/ml) in the continued presence of wortmannin. Concentrations of IL-4 in the conditioned medium (A) and in the cells (B) at 4 h
were determined by ELISA. Vertical bars represent S.E.M. from four wells. (C) Two hours after the antigen stimulation, total RNA
was extracted and the levels of mRNA for IL-4 and GAPDH were detected by RT-PCR as described in Section 2.2. The ratio of IL-
4 mRNA density to GAPDH mRNA density was determined in three independent experiments and indicated in the lower panel. The
density ratio of the antigen-stimulated control is set to 1.0. Statistical signi¢cance; *P6 0.05, **P6 0.01 and ***P6 0.001 vs. the
antigen-stimulated control.
Fig. 1. Time course of IL-4 mRNA levels and IL-4 production
in the antigen-stimulated RBL-2H3 cells. IgE-sensitized RBL-
2H3 cells (1U106 cells (A) or 2U105 cells (B)) were stimulated
with DNP-HSA (50 ng/ml) for the periods indicated. (A) Total
RNA was extracted and the levels of mRNA for IL-4 and
GAPDH were detected by RT-PCR as described in Section 2.2.
(B) The concentrations of IL-4 in the conditioned medium were
determined by ELISA. Closed squares indicate IL-4 concentra-
tions in the conditioned medium of unstimulated cells. Vertical
bars represent S.E.M. from four wells. The results were con-
¢rmed by two additional independent experiments.
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3. Results
3.1. IL-4 production induced by the antigen in
RBL-2H3 cells
IgE-sensitized RBL-2H3 cells were stimulated by
the antigen for the periods indicated, and then the
IL-4 levels in the conditioned medium and the IL-4
mRNA levels were determined. As shown in Fig. 1B,
IL-4 was detected at 2 h and attained the maximum
level 4 h after the antigen stimulation. IL-4 mRNA
was not detected in the non-stimulated cells, whereas
the antigen stimulation markedly increased the IL-4
mRNA level with a maximum at 2 h (Fig. 1A).
3.2. E¡ects of the PI3-kinase inhibitor wortmannin
and LY294002 on the antigen-induced IL-4
production
Pretreatment for 10 min with wortmannin de-
creased the IL-4 levels in the conditioned medium
4 h after the antigen stimulation in a concentra-
tion-dependent manner (Fig. 2A). To clarify whether
wortmannin inhibits IL-4 production or its release
to medium from inside the cells, IL-4 levels in the
cells and IL-4 mRNA levels 2 h after the antigen
stimulation were determined. As shown in Fig.
2B,C, wortmannin reduced both the IL-4 levels in
the cells and the IL-4 mRNA levels. Another PI3-
kinase inhibitor LY294002 also reduced the IL-4 lev-
els in the conditioned medium (Fig. 3A) and IL-4
mRNA levels (Fig. 3B) in a concentration-dependent
manner.
3.3. E¡ects of wortmannin on the activation of ERK,
p38 MAPK and JNK
The activation of ERK was determined by the
mobility shift of ERK in SDS-PAGE. The mobility
shift was induced 2 min after the antigen stimulation
and continued for at least 60 min (Fig. 4A). Pretreat-
Fig. 3. E¡ects of LY294002 on the antigen-induced IL-4 pro-
duction. IgE-sensitized RBL-2H3 cells (2U105 cells (A) or
1U106 cells (B)) were treated for 10 min in the presence of the
indicated concentrations of LY294002, then stimulated with
DNP-HSA (50 ng/ml) in the continued presence of LY294002.
(A) Concentrations of IL-4 in the conditioned medium at 4 h
were determined by ELISA. Vertical bars represent S.E.M.
from four wells. Statistical signi¢cance; *P6 0.05 and
***P6 0.001 vs. the antigen-stimulated control. (B) Two hours
after the antigen stimulation, total RNA was extracted and the
levels of mRNA for IL-4 and GAPDH were detected by RT-
PCR as described in Section 2.2. The numbers in parentheses in
B indicate the ratio of IL-4 mRNA density to GAPDH mRNA
density. The density ratio of the antigen-stimulated control is
set to 1.0.
Fig. 4. Antigen-induced activation of ERK and e¡ects of wort-
mannin. (A) IgE-sensitized RBL-2H3 cells (5U105 cells) were
stimulated with DNP-HSA (50 ng/ml) for the periods indicated.
(B) The cells were preincubated for 10 min in the presence of
the indicated concentrations of wortmannin, then stimulated
with DNP-HSA (50 ng/ml) for 2 min in the continued presence
of wortmannin. Proteins in the cell lysate were separated by
electrophoresis on an 8% SDS-PAGE gel and ERK was immu-
noblotted. Phosphorylated ERK ( -ERK) and unphosphory-
lated ERK (ERK) are indicated. The numbers in parentheses in
B indicate the proportion of the phosphorylated ERK as deter-
mined by densitometric analysis. The results were con¢rmed by
two additional independent experiments.
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ment with wortmannin at 100 nM resulted in partial
reduction of the percentage of upper band (phos-
phorylated ERK) at 2 min, but the reduction by 10
and 30 nM wortmannin was very slight (Fig. 4B).
After the antigen stimulation, phosphorylation of
p38 MAPK increased from 10 to 40 min, but p38
MAPK protein content did not change during the
period examined (Fig. 5A). The increases in the
phosphorylation (Fig. 5B) and the kinase activity
(Fig. 5C) of p38 MAPK 20 min after the antigen
stimulation were markedly inhibited by the pretreat-
ment with wortmannin at 10 and 100 nM.
The antigen stimulation induced the phosphoryla-
tion of JNKs, p46 JNK (JNK1) and p54 JNK
(JNK2). The increase in the phosphorylation of
JNKs 40 min after the antigen stimulation was re-
duced by the pretreatment with wortmannin at 10
and 100 nM, although the protein contents of
JNK2 were not changed (Fig. 6).
3.4. E¡ects of wortmannin on the antigen-induced
ATF-2 phosphorylation
As an index of p38 MAPK activity in the antigen-
stimulated cells, the phosphorylation of endogenous
ATF-2 was determined. The phosphorylation of
ATF-2 increased time-dependently until 20 min after
the antigen challenge and then declined, without
changes in ATF-2 protein contents (Fig. 7A). The
phosphorylation of ATF-2 at 20 min was inhibited
by wortmannin in a concentration-dependent manner
(Fig. 7B).
3.5. E¡ects of the MEK-1 inhibitor PD98059 on the
antigen-induced ERK activation and IL-4
production
PD98059 was used to examine the role of ERK in
Fig. 5. Antigen-induced activation of p38 MAPK and e¡ects of
wortmannin. (A) IgE-sensitized RBL-2H3 cells (5U105 cells)
were stimulated with DNP-HSA (50 ng/ml) for the periods indi-
cated. (B) IgE-sensitized RBL-2H3 cells (5U105 cells) were pre-
incubated for 10 min in the presence of the indicated concentra-
tions of wortmannin, then stimulated with DNP-HSA (50 ng/
ml) for 20 min in the continued presence of wortmannin. Pro-
teins in the cell lysate were separated by electrophoresis on an
8% SDS-PAGE gel and p38 MAPK and phospho-p38 MAPK
were immunoblotted. The numbers in parentheses in B indicate
the fold increase in phospho-p38 MAPK as determined by den-
sitometric analysis. The value of the unstimulated control is set
to 1.0. (C) IgE-sensitized RBL-2H3 cells (1U106 cells) were
treated as described in B, and the p38 MAPK activity in the
cell lysate was determined as described in Section 2.2. The
phosphorylation of ATF-2 was analyzed by autoradiography
and a Bioimage analyzer. The value of the unstimulated control
is set to 1.0. The results were con¢rmed by two additional inde-
pendent experiments. Fig. 6. E¡ects of wortmannin on the antigen-induced phosphor-
ylation of JNK. IgE-sensitized RBL-2H3 cells (5U105 cells)
were preincubated for 10 min in the presence of the indicated
concentrations of wortmannin, then stimulated with DNP-HSA
(50 ng/ml) for 40 min in the continued presence of wortmannin.
Proteins in the cell lysate were separated by electrophoresis on
an 8% SDS-PAGE gel and phospho-JNK was immunoblotted.
Then, JNK on the same membrane was reblotted. Phosphory-
lated JNK ( -JNK1 and -JNK2) and JNK2 are indicated.
The numbers in parentheses indicate the fold increase in the
phosphorylated JNK as determined by densitometric analysis.
The results were con¢rmed by two additional independent ex-
periments.
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IL-4 production. Pretreatment with PD98059 for
10 min inhibited the antigen-induced mobility shift
of ERK at 2 min in a concentration-dependent man-
ner (Fig. 8A). PD98059 at these concentrations en-
hanced the antigen-induced IL-4 production (Fig.
8B).
Fig. 7. Antigen-induced phosphorylation of endogenous ATF-2
and e¡ects of wortmannin. (A) IgE-sensitized RBL-2H3 cells
(1.0U106) were stimulated with DNP-HSA (50 ng/ml) for the
periods indicated. (B) The cells were preincubated for 10 min in
the presence of the indicated concentrations of wortmannin,
then stimulated with DNP-HSA (50 ng/ml) for 20 min in the
continued presence of wortmannin. Proteins in the nuclear ex-
tracts were separated by electrophoresis on an 8% SDS-PAGE
gel, and ATF-2 and phosphorylated ATF-2 (phospho-ATF-2)
were immunoblotted. The numbers in parentheses in B indicate
the fold increase in phospho-ATF-2 as determined by densito-
metric analysis. The value of the unstimulated control is set to
1.0. The results were con¢rmed by two additional independent
experiments.
Fig. 8. E¡ects of PD98059 on the antigen-induced ERK activa-
tion and IL-4 production. IgE-sensitized RBL-2H3 cells (5U105
cells (A) or 2U105 cells (B)) were preincubated for 10 min in
the presence of PD98059 at the indicated concentrations, then
stimulated with DNP-HSA (50 ng/ml) for 2 min (A) or 4 h (B)
in the continued presence of PD98059. (A) ERK activation was
determined as described in the legend to Fig. 3. The numbers
in parentheses indicate the fold increase in the phosphorylated
ERK ( -ERK) as determined by densitometric analysis.
(B) Concentrations of IL-4 in the conditioned medium at 4 h
was determined by ELISA. Vertical bars represent S.E.M. from
four wells. The results were con¢rmed by two additional
independent experiments. Statistical signi¢cance; **P6 0.01 and
***P6 0.001 vs. the antigen-stimulated control.
Fig. 9. E¡ects of SB203580 on the antigen-induced activation
of p38 MAPK and IL-4 production. (A) IgE-sensitized RBL-
2H3 cells (1U106 cells) were stimulated with DNP-HSA (50 ng/
ml) for 20 min. Kinase activities in the anti-p38 MAPK immu-
noprecipitates from the cell lysates were determined in the pres-
ence of the indicated concentrations of SB203580. (B) IgE-sensi-
tized cells (2U105 cells) were preincubated for 10 min in the
presence of the indicated concentrations of SB203580, then
stimulated for 4 h with DNP-HSA (50 ng/ml) in the continued
presence of SB203580. Concentrations of IL-4 in the condi-
tioned medium were determined by ELISA. Vertical bars repre-
sent S.E.M. from four wells. The results were con¢rmed by two
additional independent experiments. (C) Two hours after the
addition of the antigen, total RNA was extracted and levels of
mRNA for IL-4 and GAPDH were detected by RT-PCR as de-
scribed in Section 2.2. The numbers in parentheses in C indicate
the ratio of IL-4 mRNA density to GAPDH mRNA density.
The density ratio of the antigen-stimulated control is set to 1.0.
The results were con¢rmed by two additional independent ex-
periments.
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3.6. E¡ect of the p38 MAPK inhibitor SB203580 on
IL-4 production
SB203580 at 1 and 3 WM completely inhibited p38
MAPK activity in vitro (Fig. 9A). However, as
shown in Fig. 9B, SB203580 at concentrations up
to 3 WM showed partial inhibition of the antigen-
induced IL-4 production at 4 h. The e¡ect was a
concentration-dependent, and maximum inhibition
was attained at 1 WM SB203580. The antigen-in-
duced increase in the level of IL-4 mRNA at 2 h
was also partially inhibited by 1 and 3 WM
SB203580 (Fig. 9C).
4. Discussion
The ¢ndings of the present study indicated that
PI3-kinase^p38 MAPK pathway is partially, but sig-
ni¢cantly, involved in the antigen-induced IL-4 pro-
duction by rat mast cells. The antigen-stimulated
mast cells produce several cytokines, such as IL-4
[1], IL-6 [33] and TNF-K [34]. The PI3-kinase inhib-
itor wortmannin does not inhibit IL-6 production
[33], but partially inhibits production of IL-4 (this
paper) and TNF-K [21]. In contrast with IL-4 pro-
duction, the antigen-induced TNF-K production is
not inhibited by the p38 MAPK inhibitor, but is
regulated by a MEKK-JNK pathway which is also
inhibited by wortmannin [22]. Thus, the production
of each cytokine by the antigen-stimulated mast cells
is regulated in a di¡erent way.
PI3-kinase plays important roles not only in the
degranulation of mast cells [22^24,33], but also in
the vesicle transport [35]. Although IL-4 release is
dependent on the vesicle transport and/or the de-
granulation, it is unlikely that the release of IL-4
from mast cells is inhibited by wortmannin, because
wortmannin reduced the levels of IL-4 both in the
cells and in the conditioned medium (Fig. 2A,B). In
addition, wortmannin-induced reduction of IL-4
mRNA levels (Fig. 2C) paralleled the reduction of
IL-4 levels in the conditioned medium (Fig. 2A), in-
dicating that wortmannin partially inhibits IL-4 pro-
duction at mRNA level. Although wortmannin in-
hibits other enzymes, such as myosin light chain
kinase [22], inhibition of IL-4 production by wort-
mannin seemed to be due to the inhibition of PI3-
kinase, because the other inhibitor of PI3-kinase,
LY294002 [26], also inhibited the antigen-induced
IL-4 production (Fig. 3). In addition, SB203580, an
inhibitor of p38 MAPK, partially inhibited IL-4 pro-
duction (Fig. 9B) in parallel with the reduction of
IL-4 mRNA levels (Fig. 9C), indicating that
SB203580 also inhibits IL-4 production at mRNA
level. These ¢ndings indicate that PI3-kinase and
p38 MAPK regulate the transcription of IL-4 gene.
However, it remains to be elucidated whether wort-
mannin and SB203580 reduce the stability of IL-4
mRNA, and whether they inhibit the translation of
IL-4.
PI3-kinase regulates the activation of small G-pro-
teins, such as Rac [12,13], which activates p21-acti-
vated kinase [14,36] resulting in the activation of a
p38 MAPK pathway. The activation of Rac also
leads to the activation of JNK pathway [15]. Wort-
mannin inhibits both JNK phosphorylation (Fig. 6)
and p38 MAPK activation (Fig. 5) indicating that
wortmannin inhibits these MAP kinase activation
via the inhibition of the Rac activation. In a cell-
free system, it is reported that the Rac activation
by tyrosine-phosphorylated Vav is inhibited by the
substrates of PI3-kinase, but is enhanced by the
products of PI3-kinase [37]. In addition, Bruton’s
tyrosine kinase is involved in antigen-induced activa-
tion of JNK in mast cells [38] and wortmannin and
LY294002 inhibit the Bruton’s tyrosine kinase-de-
pendent activation of JNK [39]. Further investigation
is necessary to clarify whether Vav and Bruton’s ty-
rosine kinase also regulate in the activation of p38
MAPK in the antigen-stimulated mast cells.
In the present study, wortmannin inhibited JNK
phosphorylation (Fig. 6) consistent with our previous
¢nding that wortmannin inhibits the antigen-induced
JNK activation [16]. Inhibition by wortmannin of
JNK activation was less than that of p38 MAPK.
Our ¢nding does not coincide with the report by
Ishizuka et al. [21] indicating that, in mouse mast
cell line MC/9, wortmannin completely inhibits the
antigen-induced JNK activation, but partially inhib-
its p38 MAPK activation. Therefore, it is possible
that the signaling pathway for the activation of p38
MAPK and JNK is di¡erent between RBL-2H3 cells
and MC/9 cells. In contrast, wortmannin did not
inhibit the activation of ERK in both RBL-2H3 cells
(Fig. 4) and MC/9 cells [21]. Thus, PI3-kinase regu-
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lates the activation of p38 MAPK and JNK, but not
ERK in mast cells, and the inhibitors of PI3-kinase
might be useful to clarify roles of p38 MAPK and
JNK in mast cells.
IL-4 transcription in mast cells and T-cells is
mainly regulated by NF-AT and AP-1 [4,9]. The ac-
tivation of NF-AT alone induces IL-4 production,
and AP-1 enhances the NF-AT-induced responses
[4]. Although PI3-kinase is suggested to be involved
in NF-AT activation, wortmannin does not inhibit
NF-AT activation in T-cells [40]. Therefore, wort-
mannin might inhibit, through inhibiting the activa-
tion of p38 MAPK and JNK, the activation of AP-1,
but not NF-AT, in the antigen-stimulated mast cells
resulting in the partial inhibition of IL-4 production.
The precise mechanism by which p38 MAPK reg-
ulates IL-4 transcription remains to be elucidated.
Although ATF-2, which forms heterodimer with
cAMP responsive element (CRE) binding protein
family members or AP-1 components, binds to
CRE, CRE is not found in the IL-4 promoter region
[5^7]. p38 MAPK also phosphorylates another tran-
scription factor, myocyte-enhancer factor 2C, which
is involved in the induction of c-Jun expression [41].
Because the antigen stimulation induces c-fos and
c-jun expression [42], p38 MAPK might play a role
in the induction of AP-1 components.
In contrast with p38 MAPK, the antigen-induced
activation of ERK was not inhibited by wortmannin
(Fig. 4). However, our ¢nding that PD98059, a
MEK-1 inhibitor, enhanced the antigen-stimulated
IL-4 production (Fig. 8) suggests that ERK nega-
tively regulates the antigen-induced IL-4 production.
ERK induces the MAPK phosphatase MKP-3 [43]
which deactivates MAPKs. In addition, inhibition of
ERK by PD98059 activates p38 MAPK in HeLa
cells [44]. Thus, ERK might regulate activation of
p38 MAPK and JNK. In addition, because
PD98059 enhances the antigen-induced expression
of a reporter construct under the control of TNF-K
promoter [21], ERK might have some unidenti¢ed
regulatory roles in gene expression of certain cyto-
kines.
In conclusion, PI3-kinase regulates the antigen-in-
duced activation of p38 MAPK and JNK, and the
PI3-kinase/p38 MAPK pathway is involved, in part,
in the antigen-induced IL-4 production in RBL-2H3
cells.
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